|
Kidney Failure, Acute
|
0.100 |
Biomarker
|
disease |
BEFREE |
In experimental models of AKI, infusion of NP prevented post-ischemic fall in renal blood flow (RBF) or improvement in RBF, GFR, diuresis and natriuresis and demonstrated anti-inflammatory properties.
|
31812538 |
2020 |
|
Kidney Failure, Acute
|
0.100 |
Biomarker
|
disease |
BEFREE |
The use of timed urine collections, kinetic eGFR (estimated glomerular filtration rate), real time measurement of GFR and direct measures of tubular damage can theoretically aid in a more timely diagnosis of AKI and improve patients' outcome.
|
30523562 |
2019 |
|
Kidney Failure, Acute
|
0.100 |
Biomarker
|
disease |
BEFREE |
Especially, when GFR ≥30 mL/min, higher BMI increased the risk of the 28-day mortality rate in patients with AKI undergoing CRRT.
|
31424314 |
2019 |
|
Kidney Failure, Acute
|
0.100 |
Biomarker
|
disease |
BEFREE |
And AKI was defined based on the KDIGO criteria but GFR or urinary output assessment was not used.
|
29299948 |
2018 |
|
Kidney Failure, Acute
|
0.100 |
Biomarker
|
disease |
BEFREE |
A chronic kidney disease (CKD) group and an acute kidney injury (AKI) group were defined based on GFR measurements during and before index hospitalization.
|
29396621 |
2018 |
|
Kidney Failure, Acute
|
0.100 |
Biomarker
|
disease |
BEFREE |
AKI is defined as a new-onset 1.5-fold or more increase in serum creatinine or a 25% decrease in estimated GFR sustained for at least 3 days despite volume resuscitation.The primary outcome is AKI.
|
28756545 |
2018 |
|
Kidney Failure, Acute
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
AKI accuracy defined by the estimated reference SCr, the average SCr value of the non-AKI population (eb-GFR-A approach), or the back-calculated SCr from fixed eGFR = 75 mL/min/1.73 m<sup>2</sup> (eGFR 75 approach, or, eb-GFR-B approach in this study), was evaluated.
|
28983757 |
2018 |
|
Kidney Failure, Acute
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The serum creatinine (SCr) level returned to normal in six patients including five with ARF and one with A on C, while those of the rest four patients with A on C restored to baseline levels (GFR remained below 60 ml/min/1.73 m<sup>2</sup> however) after therapy.
|
29416818 |
2018 |
|
Kidney Failure, Acute
|
0.100 |
Biomarker
|
disease |
BEFREE |
Although patients who received Polymyxin B plus vancomycin had more favorable clinical profile and higher previous GFR, they presented a higher AKI incidence than those patients who received Polymyxin B alone.
|
28353411 |
2017 |
|
Kidney Failure, Acute
|
0.100 |
Biomarker
|
disease |
BEFREE |
Real-time monitoring of GFR in critically ill patients will allow for earlier diagnosis of acute kidney injury and a dynamic metric to guide therapeutics.
|
28953557 |
2017 |